Moderate riskFDA DeviceClass II

Diagnostica Stago STA Staclot Protein S reagent recalled for QC drift

Diagnostica Stago identified a positive drift in quality control (QC) values in one lot of STA Staclot Protein S reagent within the product's stated 4-hour stability period. This drift could affect the accuracy of test results performed during that window. The issue affects reagent Lot 273074 distributed nationwide.

From the FDA notice · Read the official notice ↗ · All Diagnostica Stago recalls

What to do

  1. Check your facility's inventory for STA Staclot Protein S Lot 273074 (Exp 3/31/2027).
  2. Contact Diagnostica Stago or your supplier for instructions on return or replacement.
  3. Review any patient results generated with this lot and follow your laboratory's quality protocol.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test
Sold in
Nationwide
Made for
All ages

Details

Units affected
5220 units
Illnesses reported
None reported
Manufactured in
5 Century Dr, N/A, Parsippany, NJ, United States
Classification
Class II
Recall number
Z-3047-2026

In the FDA's words

Description
STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027 Distribution: US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR. Affected quantity: 5220 units
Hazard
A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

Related topics